Global Marine Biotechnology Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024

Industry : Healthcare Date : March 4th, 2019
Tutorials Get 15% Discount on First Report

The global marine biotechnology market is expected to grow significantly from USD 3,500.4 million in 2017 to USD 6,500.6 million in 2024, at a CAGR of 9.61% from 2018 to 2024. The growth in the market is attributed to the rising usage of marine biotechnology in various industries, advances in drug discovery and growing expenditure in R&D activities. Moreover, increasing demand for eco-friendly products is further propelling the market growth.

The years used for the assessment are as follows;

Historical year:2014, 2015, and 2016

Base year:2017

Forecast period:2018 – 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

  • Obtaining historical data of the market based on news, articles, publications, government websites, annual reports, press releases, white papers, surveys, investor presentation of companies, and other secondary sources
  • Interacting with key opinion leaders of the market and developing data points based on interaction with them
  • Study of past trends in the market and their year on year Impact on the market size and share
  • Analyzing the collected data points
  • Bridging the data points to calculate the total global marine biotechnology market and its various segments
  • Anticipating potential risks
  • Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global marine biotechnology market
  • Finalizing the overall size and share of the global marine biotechnology market

OBJECTIVES:

  • To analyze market trends, opportunities, drivers, and restraints associated with the global marine biotechnology market
  • To study market response with respect to the mergers and acquisitions in the industry
  • To profile key companies operating in the marine biotechnology market and provide their competitive landscape

MARKET SCOPE

The research scope for global marine biotechnology market is as follows:

Source

  • Algae
  • Annelids
  • Bacteria
  • Bryozoa
  • Cnidaria
  • Crustacea
  • Fungi
  • Echinoderms
  • Fishes
  • Molluscs
  • Nemertinea
  • Protozoa

Product

  • Bio Active Substances
  • Bio Material
  • Others

Technology

  • Isolation and Cultivation of Microorganisms
  • Culture-Independent Techniques

Application

  • Aquaculture and Food Products
  • Environmental and Human Health
  • Drug Discovery
  • Pollution Remediation
  • Wastewater & Waste Disposal
  • Biofuels
  • Others

End-user

  • Food Industry
  • Pharmaceutical and Biotech
  • Cosmetics
  • Chemical
  • Energy
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Central & South America
  • Middle East and Africa (MEA)

Marine biotechnology contributes to various other biotechnology and industry sectors from pharmaceutical to cosmetics and bioremediation to energy. Marine biotechnology is key to realizing the potential of marine bio-resource. These resources could produce new products and processes, and help address the global challenges of energy, food and health.

Geographically, Europe held the largest share of the market in 2017. The growth in the region is attributed to the technological advancements in marine biotechnology, growing demand from cosmetic industry, and increasing demand of marine biotechnology for the development of biofuels. The growth of marine biotechnology market in North America is primarily attributed to the growing research and development activities, and increasing demand for natural products. Moreover, rapid growth in healthcare industry, and demand of marine products in agriculture, cosmetics, and, food industries are further propelling the market growth in the region. Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to the growing investment in the marine-based healthcare and cosmetic markets, and extensive aquaculture activity, including culturing macro-algae for hydrocolloids. Moreover, positive trends towards organic cosmetics and rising demand for viable eco-friendly products are further boosting the market growth in the region.

Some of the key companies operating in the market include Sea Run Holdings, Inc., Aker Biomarine, PharmaMar , SEPPIC , New England Biolabs Inc., CoDo International Limited, Marinomed Biotech AG, Cyanotech Corporation, CP Kelco US Inc, and AlgaEnergy S.A. among others.Global Marine Biotechnology Market

TABLE OF CONTENTS

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology

1.2. Research scope & assumptions

1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Marine Biotechnology- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition

3.2. Market segmentation

3.3. Key findings of the global marine biotechnology market

3.4. Value chain analysis

3.4.1. By end-use Industries

3.5. Market opportunities & trends

3.5.1. Increasing usage of marine biotechnology for the development of biofuels

3.5.2. Rising investment and collaborations in translational research

3.6. Market driver analysis

3.6.1. Rising usage of marine biotechnology in various industries

3.6.2. Advances in drug discovery

3.6.3. Increasing demand for eco-friendly products

3.7. Market restraint analysis

3.7.1. Fluctuations in prices of crude oil

3.7.2. Difficulty in sampling the huge diversity of resources

CHAPTER 4. Competitive Outlook

4.1. Competitive analysis

4.1.1. Industry Analysis-Porters five forces analysis

4.1.2. Company Share Analysis

4.2. Competitive factors

CHAPTER 5. Global Marine Biotechnology Market Size and Forecast (2014 – 2024)

5.1. Global Marine Biotechnology Market, By Source

5.1.1. Algae

5.1.2. Annelids

5.1.3. Bacteria

5.1.4. Bryozoa

5.1.5. Cnidaria

5.1.6. Crustacea

5.1.7. Fungi

5.1.8. Echinoderms

5.1.9. Fishes

5.1.10. Molluscs

5.1.11. Nemertinea

5.1.12. Protozoa

5.2. Global Marine Biotechnology Market, By Product

5.2.1. Bio Active Substances

5.2.2. Bio Material

5.2.3. Others

5.3. Global Marine Biotechnology Market, By Technology

5.3.1. Isolation and Cultivation of Microorganisms

5.3.2. Culture-Independent Techniques

5.4. Global Marine Biotechnology Market, By Application

5.4.1. Aquaculture and Food Products

5.4.2. Environmental and Human Health

5.4.3. Drug Discovery

5.4.4. Pollution Remediation

5.4.5. Wastewater & Waste Disposal

5.4.6. Biofuels

5.4.7. Others

5.5. Global Marine Biotechnology Market, By End-user

5.5.1. Food Industry

5.5.2. Pharmaceutical and Biotech

5.5.3. Cosmetics

5.5.4. Chemical

5.5.5. Energy

5.5.6. Others

CHAPTER 6. Global Marine Biotechnology Market, By Geography

6.1. North America Marine Biotechnology Market

6.1.1. North America Marine Biotechnology Market, By Source (USD Million)

6.1.2. North America Marine Biotechnology Market, By Product (USD Million)

6.1.3. North America Marine Biotechnology Market, By Technology (USD Million)

6.1.4. North America Marine Biotechnology Market, By Application (USD Million)

6.1.5. North America Marine Biotechnology Market, By End-user (USD Million)

6.1.6. North America Marine Biotechnology Market, By Country

   6.1.6.1. U.S.

   6.1.6.2. Canada

   6.1.6.3. Mexico

6.2. Europe Marine Biotechnology Market

6.2.1. Europe Marine Biotechnology Market, By Source (USD Million)

6.2.2. Europe Marine Biotechnology Market, By Product (USD Million)

6.2.3. Europe Marine Biotechnology Market, By Technology (USD Million)

6.2.4. Europe Marine Biotechnology Market, By Application (USD Million)

6.2.5. Europe Marine Biotechnology Market, By End-user (USD Million)

6.2.6. Europe Marine Biotechnology Market, By Country

   6.2.6.1. Austria

   6.2.6.2. Norway

   6.2.6.3. Spain

   6.2.6.4. UK

   6.2.6.5. Belgium

   6.2.6.6. Denmark

   6.2.6.7. Germany

   6.2.6.8. Greece

   6.2.6.9. Italy

   6.2.6.10. Spain

   6.2.6.11. France

   6.2.6.12. Rest of Europe

6.3. Asia-Pacific Marine Biotechnology Market

6.3.1. Asia-Pacific Marine Biotechnology Market, By Source (USD Million)

6.3.2. Asia-Pacific Marine Biotechnology Market, By Product (USD Million)

6.3.3. Asia-Pacific Marine Biotechnology Market, By Technology (USD Million)

6.3.4. Asia-Pacific Marine Biotechnology Market, By Application (USD Million)

6.3.5. Asia-Pacific Marine Biotechnology Market, By End-user (USD Million)

6.3.6. Asia-Pacific Marine Biotechnology Market, By Country

   6.3.6.1. China

   6.3.6.2. Australia

   6.3.6.3. Japan

   6.3.6.4. South Korea

   6.3.6.5. India

   6.3.6.6. Rest of Asia-Pacific

6.4. Centeral and South America Marine Biotechnology Market

6.4.1. Centeral and South America Marine Biotechnology Market, By Source (USD Million)

6.4.2. Centeral and South America Marine Biotechnology Market, By Product (USD Million)

6.4.3. Centeral and South America Marine Biotechnology Market, By Technology (USD Million)

6.4.4. Centeral and South America Marine Biotechnology Market, By Application (USD Million)

6.4.5. Centeral and South America Marine Biotechnology Market, By End-user (USD Million)

6.4.6. Centeral and South America Marine Biotechnology Market, By Country

   6.4.6.1. Brazil

   6.4.6.2. Argentina

   6.4.6.3. Rest of Central and South America

6.5. Middle East and Africa Marine Biotechnology Market

6.5.1. Middle East and Africa Marine Biotechnology Market, By Source (USD Million)

6.5.2. Middle East and Africa Marine Biotechnology Market, By Product (USD Million)

6.5.3. Middle East and Africa Marine Biotechnology Market, By Technology (USD Million)

6.5.4. Middle East and Africa Marine Biotechnology Market, By Application (USD Million)

6.5.5. Middle East and Africa Marine Biotechnology Market, By End-user (USD Million)

   6.5.5.1. South Africa

   6.5.5.2. Saudi Arabia

   6.5.5.3. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments

7.1. Sea Run Holdings, Inc.

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. Aker Biomarine

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. PharmaMar

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. SEPPIC

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. New England Biolabs Inc.

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. CoDo International Limited

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. Marinomed Biotech AG

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. Cyanotech Corporation

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. CP Kelco US Inc

7.9.1. Business Overview

7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. AlgaEnergy S.A

7.10.1. Business Overview

7.10.2. Product and Service Offering

7.10.3. Financial Overview

7.10.4. Strategic Developments

7.11. Abbreviation

Global Marine Biotechnology Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation and Forecast 2024